Not logged in Share Save
Share Save
Share Save
Share Save
Share Save
IMpower010: 5-Year Outcomes of Atezolizumab in Japanese Patients With Resected Stage IB-IIIA Non-Small Cell Lung Cancer Okada, Morihito; Sugawara, Shunichi; Watanabe, Yasutaka; Saito, Haruhiro; Chen-yoshikawa, Toyofumi F.; Goto, Yasushi; Nishio, Wataru; Nakagawa, Shizuka; Hayashi, Morihiko; Kenmotsu, Hirotsugu Share Save
Share Save
Real-world outcomes and association between immune-related adverse events and therapeutic efficacy of nivolumab plus ipilimumab in elderly patients (≥75 years) with advanced non-small cell lung cancer Minami, Soichiro; Doman, Tsuyoshi; Toi, Yukihiro; Fukuzawa, Keito; Yamazaki, Yusuke; Saito, Shin; Narumi, Akane; Odaka, Tetsuo; Ogasawara, Takahiro; Shimizu, Hisashi; Sugisaka, Jun; Ono, Kana; Aiba, Tomoiki; Kawana, Sachiko; Yamanda, Shinsuke; Kimura, Yuichiro; Sugawara, Shunichi Share Save
Share Save
A case of lower respiratory tract infection caused by Pandoraea sputorum in a human T-lymphotropic virus type 1 carrier Ogasawara, Takahiro; Yamanda, Shinsuke; Fukuzawa, Keito; Yamazaki, Yusuke; Doman, Tsuyoshi; Minami, Soichiro; Narumi, Akane; Saito, Shin; Odaka, Tetsuo; Ono, Kana; Shimizu, Hisashi; Sugisaka, Jun; Aiba, Tomoiki; Kawana, Sachiko; Toi, Yukihiro; Sugawara, Shunichi; Kimura, Yuichiro Share Save
Share Save
Share Save
Prospective Multi-Institutional Observational Study of Retreatment with Anti-PD-1/PD-L1 Antibodies in Patients with Non-Small Cell Lung Cancer Previously Treated with Anti-PD-1/PD-L1 Plus Chemotherapy: NJLCG (North Japan Lung Cancer Group) Trial 1901 Saito, Shin; Kawashima, Yosuke; Tanaka, Hisashi; Yoshimura, Naruo; Tsukita, Yoko; Saito, Ryota; Nakagawa, Taku; Inomata, Minehiko; Nagashima, Hiromi; Sugawara, Shunichi Share Save
Share Save
First-line nivolumab plus platinum chemotherapy and bevacizumab for advanced nonsquamous non-small cell lung cancer: A 3-year follow-up of the phase 3 randomized TASUKI-52 trial Lee, Ki Hyeong; Lee, Jong-Seok; Sugawara, Shunichi; Kang, Jin Hyoung; Kim, Hye Ryun; Inui, Naoki; Hida, Toyoaki; Yoshida, Tatsuya; Tanaka, Hiroshi; Yang, Cheng-Ta; Inoue, Takako; Nishio, Makoto; Ohe, Yuichiro; Tamura, Tomohide; Yamamoto, Nobuyuki; Yu, Chong-Jen; Akamatsu, Hiroaki; Takahashi, Shigeru Share Save
Longitudinal recurrence risk of adjuvant cytotoxic chemotherapy and gefitnib in resected lung cancer: A combined analysis of phase III studies Akamatsu, Hiroaki; Nishikawa, Tomomi; Takeda, Yuriko; Misumi, Toshihiro; Aoki, Tadashi; Shoda, Hiroyasu; Yamashita, Motohiro; Sakakura, Noriaki; Daga, Haruko; Sugawara, Shunichi; Okishio, Kyoichi; Kenmotsu, Hirotsugu; Yamamoto, Nobuyuki; Tada, Hirohito; Tsuboi, Masahiro; Mitsudomi, Tetsuya Share Save
Efficacy and safety of brigatinib in patients with ALK TKI-naive advanced ALK plus NSCLC: Integrated analysis of the ALTA-1L and J-ALTA trials Camidge, D. Ross; Sugawara, Shunichi; Kondo, Masashi; Kim, Hye Ryun; Ahn, Myung-Ju; Yang, James C. H.; Hochmair, Maximilian J.; Lee, Ki Hyeong; Delmonte, Angelo; Kudou, Kentarou; Asato, Takayuki; Hupf, Bradley; Vranceanu, Florin; Fram, Robert J.; Ohe, Yuichiro; Popat, Sanjay Share Save
Share Save
Efficacy and safety of datopotamab deruxtecan (Dato-DXd) in patients (pts) with previously-treated EGFR-mutated advanced non-small cell lung cancer (NSCLC): A pooled analysis of TROPION-Lung01 and TROPION-Lung05 Ahn, M-J.; Sands, J.; Lisberg, A. E.; Paz-Ares, L.; Pons-Tostivint, E.; Perol, M.; Felip, E.; Hong, M. H.; Sugawara, S.; Hayashi, H.; Cho, B. C.; Blumenschein, G.; Shum, E.; Goto, Y.; Zebger-Gong, H.; Lakshminarayanan, K.; Uema, D.; Okamoto, I.; Gu, W. Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
